← 產業報告目錄
Targeted Sequencing Market Size, Share & Trends Analysis Report By Product Type (Instruments, Kits/Panels And Assays, Services), Target Enrichment Method (Hybridization Capture, Amplicon Sequencing), Type Of Target Capture (Targeted DNA Sequencing, Targeted RNA Sequencing), Application, And End-User, By Region, And Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-26頁數 180報告編號 INSIGHTACE-e7f0e28603
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The worldwide Targeted Sequencing Market stood at USD 3.9 Bn in 2024, and is set to reach USD 14.7 Bn by 2034, recording a CAGR of 14.4% from 2025 through 2034.
Targeted Sequencing covers key industry insights & findings from the report:
The demand for personalized treatment strategies represents a substantial driver for the targeted sequencing market. Rapid advancements and evolving end-user preferences are reshaping how healthcare entities approach this space.
The market's upward path is supported by escalating healthcare spending, technological evolution, and the escalating focus on personalized and precision-based approaches in healthcare.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
From a regional perspective, mature markets in North America and Europe continue to hold substantial shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and escalating investment in the sector.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Targeted Sequencing Market Snapshot
Chapter 4. Global Targeted Sequencing Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Product Type Estimates & Trend Analysis
5.1. by Product Type & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Product Type:
5.2.1. Instruments
5.2.2. Kits/Panels and Assays
5.2.3. Services
5.2.4. Other Product Types
Chapter 6. Market Segmentation 2: by Target Enrichment Method Estimates & Trend Analysis
6.1. by Target Enrichment Method & Market Share, 2024 & 2034
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Target Enrichment Method:
6.2.1. Hybridization Capture
6.2.2. Amplicon Sequencing
6.2.3. Other Target Enrichment Methods
Chapter 7. Market Segmentation 3: by Type of Target Capture Estimates & Trend Analysis
7.1. by Type of Target Capture & Market Share, 2024 & 2034
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Type of Target Capture:
7.2.1. Targeted DNA Sequencing
7.2.1.1. Targeted Methyl Sequencing
7.2.2. Targeted RNA Sequencing
7.2.2.1. Targeted Metagenomic Sequencing
7.2.3. Other Types of Target Capture
Chapter 8. Market Segmentation 4: by Application Estimates & Trend Analysis
8.1. by Application & Market Share, 2024 & 2034
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Application:
8.2.1. Oncology
8.2.1.1. Solid Tumor
8.2.1.2. Liquid Biopsy
8.2.1.3. Minimal Residual Disease Testing
8.2.1.4. Circulating Tumor Cell (CTC) Analysis
8.2.2. Infectious Diseases
8.2.3. Cardiovascular Diseases
8.2.4. Reproductive Health
8.2.4.1. Carrier Screening
8.2.4.2. Non-Invasive Prenatal Testing
8.2.4.3. Preimplantation Genetic Diagnosis (PGD)
8.2.4.4. Newborn Screening
8.2.5. Rare Diseases
8.2.6. Neurological Disorders
8.2.7. Hereditary Diseases
8.2.8. Other Applications
Chapter 9. Market Segmentation 5: by End-User Estimates & Trend Analysis
9.1. by End-User & Market Share, 2024 & 2034
9.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by End-User:
9.2.1. Diagnostic and Clinical Laboratories
9.2.2. Academic and Research Institutions
9.2.3. Pharmaceutical and Biotech Companies
9.2.4. Other End Users
Chapter 10. Targeted Sequencing Market Segmentation 6: Regional Estimates & Trend Analysis
10.1. North America
10.1.1. North America Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034
10.1.2. North America Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Target Enrichment Method, 2021-2034
10.1.3. North America Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Type of Target Capture, 2021-2034
10.1.4. North America Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
10.1.5. North America Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
10.1.6. North America Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
10.2. Europe
10.2.1. Europe Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034
10.2.2. Europe Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Target Enrichment Method, 2021-2034
10.2.3. Europe Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Type of Target Capture, 2021-2034
10.2.4. Europe Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
10.2.5. Europe Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
10.2.6. Europe Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
10.3. Asia Pacific
10.3.1. Asia Pacific Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034
10.3.2. Asia Pacific Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Target Enrichment Method, 2021-2034
10.3.3. Asia-Pacific Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Type of Target Capture, 2021-2034
10.3.4. Asia Pacific Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
10.3.5. Asia Pacific Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
10.3.6. Asia Pacific Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
10.4. Latin America
10.4.1. Latin America Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034
10.4.2. Latin America Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Target Enrichment Method, 2021-2034
10.4.3. Latin America Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Type of Target Capture, 2021-2034
10.4.4. Latin America Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
10.4.5. Latin America Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
10.4.6. Latin America Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
10.5. Middle East & Africa
10.5.1. Middle East & Africa Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034
10.5.2. Middle East & Africa Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Target Enrichment Method, 2021-2034
10.5.3. Middle East & Africa Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Type of Target Capture, 2021-2034
10.5.4. Middle East & Africa Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
10.5.5. Middle East & Africa Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
10.5.6. Middle East & Africa Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. Agilent Technologies, Inc.
11.2.2. Azenta US, Inc. (GENEWIZ)
11.2.3. BGI Group (MGI Tech Co., Ltd.)
11.2.4. CD Genomics
11.2.5. Daicel Corporation (Daicel Arbor Biosciences)
11.2.6. Danaher. (Integrated DNA Technologies, Inc.)
11.2.7. F. Hoffmann-La Roche Ltd
11.2.8. Illumina, Inc.
11.2.9. LGC Limited (LGC Biosearch Technologies)
11.2.10. PacBio.
11.2.11. PerkinElmer Inc.
11.2.12. Psomagen
11.2.13. QIAGEN N.V.
11.2.14. Takara Bio Inc.
11.2.15. Tecan Trading AG
11.2.16. Thermo Fisher Scientific Inc.
11.2.17. Twist Bioscience
11.2.18. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們